跳至主要内容
临床试验/ACTRN12610000945022
ACTRN12610000945022招募中未知

Minimally invasive stereotactic puncture and thrombolysis therapy versus conventional craniotomy in the treatment of acute intracerebral hemorrhage:a randomized controlled trial

zhou houguang0 个研究点目标入组 300 人开始时间: 2010年11月5日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
40 Years 至 75 Years(—)
性别
All

入选标准

  • (1) diagnosed as having spontaneous hemorrhage in the basal ganglion or brain lobe of the brain by CT scan; (2) hemorrhage volume: 30–100 ml; (3) age range: 40–75 years; (4) muscle strength of the paralyzed limbs: grades 0–3 on the muscle strength scale; (5) hemorrhagic duration (from stroke onset to hospital) within 24 h; (6) informed consent from patients and/or their law representative.

排除标准

  • (1) disturbances of blood coagulation, such as thrombocytopenia, hepatitis, etc; (2) traumatic intracranial hemorrhage; (3)intracranial or general infection; (4) complicated with serious heart, liver, renal or lung disease or functional failure; (5) a previous stroke history with neurological deficits; (6) intracranial aneurysm or arteriovenous malformation complicated with hemorrhage; (7) consent form cannot be obtained from the patient herself or her law representative.

研究者

发起方
zhou houguang

相似试验